2017
Share |

Press Releases

 

 

Thursday, September 21, 2017

ISCT Completes Strategic Reorganization with CEO Appointment

ISCT announces the direct appointment of Queenie Jang as Chief Executive Officer of ISCT. The appointment is part of a strategic reorganization of the central management of ISCT following its Annual Meeting this year celebrating its 25th anniversary. Queenie Jang and her team will be tasked with managing Head Office as well as integrating the activities of the international regional committees of ISCT with the central organization. The strategic reorganization involves key new appointments as well as new facilities in Vancouver, Canada.

 

 

Wednesday, August 30, 2017

ISCT Revises Cell and Gene Therapy Industry Forecast Following FDA Novartis CTL019 Approval

The International Society for Cellular Therapy (ISCT) today announces its revised forecast for the CAR-T and cell therapy industries. The forecast follows the US approval by the FDA of the Novartis CAR-T cell therapy CTL019. It encompasses the expected cross-industry reaction to the approval, and envisions the next stages in the development of cell therapies and the industry.

Media Coverage in:

 

 

Tuesday, April 4, 2017

2017 Career Achievement Award: Adrian Gee, Ml Biol, PhD

The International Society for Cellular Therapy (ISCT) today announces that Dr. Adrian Gee, Professor of Medicine and Pediatrics at the Baylor College of Medicine in Texas, US, and Director of the Clinical Applications Laboratory at the Center for Cell and Gene Therapy, is to be awarded the 2017 ‘ISCT Career Achievement Award in Cellular Therapy’. Dr. Gee will receive the award at the ISCT 2017 Annual Meeting in London, May 3-6, as part of the Society’s 25th anniversary celebrations.

Media Coverage in: 

 

 

Thursday, March 23, 2017

ISCT Comments on Trump's Proposed Health Budget Cuts

The International Society for Cellular Therapy (ISCT) believes that the massive and unprecedented budget cuts to US governmental scientific agencies including the NIH (National Institutes of Health) and NSF (National Science Foundation) proposed by US President Trump, if implemented, will have wide ranging and potentially life threatening ramifications to science, clinical care and patients in the US and internationally.

Media Coverage in:

 

 

Monday, February 6, 2017

ISCT Statement on International Travel to the US and Other Recent US Government Executive Orders

Recent US governmental executive orders, including the proposed travel ban, create confusion and uncertainty in all aspects of society, notably including respect and support for science. Scientific discovery and development requires the free exchange of information between investigators worldwide. The Executive Order of January 27, 2017 prohibiting entry to the US of individuals from specific countries challenges the openness and transparency of scientific discussion and has an immediate and significant negative impact on scientists and physicians from these countries by preventing travel to the United States to initiate or continue education or training, engage in collaborations with colleagues, or attend and present their research at scientific meetings. This further compromises scientific activities of US academic institutions, government institutions, and industry.

Media Coverage in:

 

 

ISCT in the News

 


September 6, 2017
RegMedNet - Massimo Dominici discusses the FDA's statement on unproven cellular therapies - Click here to view

 

 

PharmaTV - ISCT Leadership discusses Cellular Therapy with PharmaTV

August 15, 2017
Kurt Gunter on Cell Medica: Transforming Patients Live Through Cellular Immunotherapy - Click here to view

August 15, 2017
Miguel Forte on the International Society for Cellular Therapy - Click here to view

August 21, 2017
Emily Culme-Seymour on Strimvelis, the Ex-vivo Stem Cell Gene Therapy to Treat ADA-SCID - Click here to view

August 21, 2017
Oscar Lee on The Importance of Collaboration in Cellular Therapy - Click here to view

August 21, 2017
John Rasko on Creating Living Therapeutics at the Royal Prince Alfred Hospital - Click here to view

 

 

May 22, 2017
Innovative District - Advances in T-Cell Immunotherapy at ISCT - Click here to view

 

 

May 16, 2017
The Pharma Letter - Stem cell therapies: can anything stop them now? - Click here to view

 

 

April 1, 2017
The Medicine Maker - Power List 100 2017 with Catherine Bollard - Click here to view

 

 

March 27, 2017
Innovation District - Cell Therapy Virtuoso: Catherine Bollard - Click here to view

 

 

February 1, 2017
The Medicine Maker - Cell Therapy Virtuoso - Click here to view

 

 

 Annual Meeting Coverage - Click here to view
Silver Jubilee Coverage - Click here to view

 

 

© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.